Profile data is unavailable for this security.
About the company
Microbix Biosystems Inc. is a Canada-based life science company, which develops and commercializes biological and technological solutions for human health and wellbeing. The Company manufactures a wide range of critical biological materials for the global diagnostics industry, mainly antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. It operates through two segments: the development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and the development and commercialization of products or technologies such as Kinlytic. Its Kinlyti urokinase is a biologic thrombolytic drug used to treat blood clots.
- Revenue in CAD (TTM)23.84m
- Net income in CAD4.06m
- Incorporated1978
- Employees69.00
- LocationMicrobix Biosystems Inc265 Watline AvenueMISSISSAUGA L4Z 1P3CanadaCAN
- Phone+1 (905) 361-8910
- Fax+1 (905) 361-8910
- Websitehttps://microbix.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Charlotte's Web Holdings Inc | 79.70m | -41.74m | 36.30m | 164.00 | -- | 0.5665 | -- | 0.4554 | -0.2721 | -0.2721 | 0.5191 | 0.406 | 0.3668 | 1.07 | 27.08 | 485,977.70 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Immunoprecise Antibodies Ltd | 23.83m | -14.35m | 38.40m | 102.00 | -- | 0.7659 | -- | 1.61 | -0.4139 | -0.4139 | 0.6861 | 1.38 | 0.2939 | 5.25 | 6.76 | 169,723.00 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| Medexus Pharmaceuticals Inc | 158.29m | 8.04m | 38.79m | 98.00 | 4.34 | 0.9557 | 2.42 | 0.245 | 0.3644 | 0.3644 | 7.28 | 1.65 | 0.7547 | 2.19 | 5.44 | 1,615,190.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
| Eastwood Bio-Medical Canada Inc | 736.75k | -531.60k | 41.49m | -- | -- | -- | -- | 56.31 | -0.0077 | -0.0077 | 0.0107 | -0.013 | 1.63 | -- | 38.65 | -- | -117.75 | -52.23 | -- | -140.29 | 60.00 | 52.09 | -72.15 | -52.90 | -- | -227.16 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| IntelGenx Technologies Corp. | 1.44m | -15.09m | 41.92m | 48.00 | -- | -- | -- | 29.16 | -0.0864 | -0.0864 | 0.0082 | -0.1203 | 0.1245 | 14.36 | 1.74 | -- | -130.62 | -75.15 | -- | -133.79 | -66.03 | -- | -1,049.48 | -819.85 | 0.1153 | -4.88 | 23.66 | -- | 9.37 | -10.65 | 7.14 | -- | -30.32 | -- |
| Auxly Cannabis Group Inc | 102.35m | -60.27m | 44.02m | 369.00 | -- | 0.4208 | -- | 0.4301 | -0.0596 | -0.0596 | 0.1017 | 0.0832 | 0.3454 | 2.26 | 5.92 | 277,374.00 | -20.34 | -21.47 | -30.18 | -24.99 | 7.93 | 5.08 | -58.89 | -124.15 | 0.3836 | -1.40 | 0.4399 | -- | 6.99 | 166.85 | 65.84 | -- | -40.92 | -- |
| Microbix Biosystems Inc | 23.84m | 4.06m | 45.18m | 69.00 | 11.16 | 1.63 | 8.27 | 1.90 | 0.0296 | 0.0296 | 0.173 | 0.202 | 0.6703 | 1.67 | 6.33 | -- | 11.42 | -0.9729 | 12.72 | -1.17 | 54.38 | 52.30 | 17.04 | -1.55 | 4.98 | 3.53 | 0.1948 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
| MustGrow Biologics Corp | 4.71m | -665.06k | 47.35m | 0.00 | -- | 10.42 | -- | 10.05 | -0.0134 | -0.0134 | 0.0936 | 0.0912 | 0.7632 | -- | 45.31 | -- | -10.77 | -50.41 | -14.00 | -59.28 | -- | -- | -14.11 | -298.73 | -- | -- | 0.1393 | -- | 72,619.13 | 372.54 | 87.84 | -- | -- | -- |
| Covalon Technologies Ltd | 26.24m | -2.77m | 52.59m | -- | -- | 2.61 | -- | 2.00 | -0.1123 | -0.1123 | 1.06 | 0.8021 | 1.02 | 1.84 | 4.53 | -- | -10.83 | -18.06 | -12.67 | -27.10 | 55.84 | 51.89 | -10.57 | -27.06 | 4.85 | -- | 0.0597 | -- | 46.56 | -0.096 | 51.79 | -- | 12.21 | -- |
| LSL Pharma Group Inc | 10.03m | -8.47m | 52.69m | -- | -- | 4.62 | -- | 5.25 | -0.1117 | -0.1117 | 0.1264 | 0.105 | -- | -- | -- | -- | -- | -- | -- | -- | 16.40 | -- | -84.48 | -- | 0.2053 | -1.14 | 0.6527 | -- | -- | -- | -- | -- | -- | -- |
